Antidiabetics

Question 1

Gliclazide

Answer 1

Sulfonylurea

Question 2

Glipizide

Answer 2

Sulfonylurea

Question 3

Glimepiride

Answer 3

Sulfonylurea

Question 4

Glibenclamide

Answer 4

Sulfonylurea

Question 5

Tolbutamide

Answer 5

Sulfonylurea

Question 6

Sulfonylurea MOA

Answer 6

Increases pancreatic insulin secretion

Question 7

Metformin MOA

Answer 7

Decreases gluconeogenesis. Increases peripheral utilisation of insulin

Question 8

Canagliflozin

Answer 8

SGLT-2 Inhibitor

Question 9

Dapagliflozin

Answer 9

SGLT-2 Inhibitor

Question 10

Empagliflozin

Answer 10

SGLT-2 Inhibitor

Question 11

SGLT-2 Inhibitor MOA

Answer 11

Reduces glucose reabsorption in the kidneys

Question 12

Sitagliptin

Answer 12

DPP4 Inhibitor

Question 13

Alogliptin

Answer 13

DPP4 Inhibitor

Question 14

Vildagliptin

Answer 14

DPP4 Inhibitor

Question 15

Saxagliptin

Answer 15

DPP4 Inhibitor

Question 16

Linagliptin

Answer 16

DPP4 Inhibitor

Question 17

DPP4 Inhibitor MOA

Answer 17

Increases insulin secretion, decreases glucagon secretion

Question 18

Pioglitazone MOA

Answer 18

Reduces peripheral insulin resistance

Question 19

Exenatide

Answer 19

GLP-1 Mimetic

Question 20

Liraglutide

Answer 20

GLP-1 Mimetic

Question 21

Semaglutide

Answer 21

GLP-1 Mimetic

Question 22

Dulaglutide

Answer 22

GLP-1 Mimetic

Question 23

GLP-1 Mimetic MOA

Answer 23

Increases insulin secretion, reduces glucagon secretion, delays gastric emptying

Question 24

Acarbose MOA

Answer 24

Delays digestion of starch and sucrose

Question 25

Repaglinide

Answer 25

Meglitinide

Question 26

Nateglinide

Answer 26

Meglitinide

Question 27

Meglitinide MOA

Answer 27

Increases pancreatic insulin secretion (same as sulfonylureas although with less hypoglycaemia) Not licensed for any other combination other than metformin